What is it about?
The clinical feasibility of using Silicon nanowire device has been demonstrated via detection of cancer marker ALCAM in serum.
Featured Image
Why is it important?
This work steps forward to the commercial feasibility of the nanowire biosensor
Perspectives
Large-scale clinical test is on the way.
Dr Duy Phu Tran
University of South Australia
Read the Original
This page is a summary of: Complementary Metal Oxide Semiconductor Compatible Silicon Nanowires-on-a-Chip: Fabrication and Preclinical Validation for the Detection of a Cancer Prognostic Protein Marker in Serum, Analytical Chemistry, February 2015, American Chemical Society (ACS),
DOI: 10.1021/ac503374j.
You can read the full text:
Resources
Contributors
The following have contributed to this page
